Apatinib is effective for treatment of advanced hepatocellular carcinoma

As treatment options for hepatocellular carcinoma (HCC) are currently limited, we evaluated the efficacy and safety of oral apatinib, a VEGFR-2 inhibitor, on patients with advanced HCC. Twenty-two patients from Tianjin Medical University Cancer Institute and Hospital were enrolled for evaluation. Ap...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Kong, Yinlong, Sun, Lin, Hou, Zhenyu, Zhang, Yongqiang, Chen, Ping, Cui, Yunlong, Zhu, Xiaolin, Song, Tianqiang, Li, Qiang, Li, Huikai, Zhang, Ti, Qin, Lunxiu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5739662/
https://ncbi.nlm.nih.gov/pubmed/29285275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22337
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia